The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nicergoline Market Research Report 2025
Synopsis
Nicergoline is an ergot derivative indicated to treat senile dementia and vascular disorders such as cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy. It is also indicated for migraines of vascular origin, coadjutant therapy in clinical situations, corio-retinal vascular disorders, oto-vestibular problems. It is sold under the brand name Sermion among others. Nicergoline is a potent vasodilator that helps improve brain blood flow by decreases vascular resistance and improving the utilization of glucose and oxygen by brain cells.
The global Nicergoline market was valued at US$ 885 million in 2023 and is anticipated to reach US$ 2354.7 million by 2030, witnessing a CAGR of 16.6% during the forecast period 2024-2030.
The global nicergoline market is projected to grow steadily. The rising burden of vascular disorders worldwide will drive the demand for Nicergoline. Rising incidences of complications due to vascular disorders are anticipated to drive the demand for Nicergoline. Increasing prevalence of cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy are projected to raise volume calls for Nicergoline. Growing FDA approval for new disease treatments is foreseen to create new growth opportunities. However, the availability of other substitutes in the market is likely to restrain the market growth. Specific challenges are roaming around the market. Adverse events have been noted associated with allergic or hypersensitivity-type reactions after the Nicergoline injection into the body. This may hinder the market growth.
This report aims to provide a comprehensive presentation of the global market for Nicergoline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicergoline.
Report Scope
The Nicergoline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicergoline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicergoline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva API
FAREVA
Olon Group
Hainan Poly Pharm Co. Ltd
DEAFARMA
Solarium Pharmaceuticals
Fengchen
LGC
Pfizer Pharmaceutical Co., Ltd.
Hebei Lingding Biotechnology Co., Ltd.
Selleck Chemicals
Tocris Bioscience
Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
Shandong Fangming Pharmaceutical Group Co. Ltd.
Hainan General Kangli Pharmaceutical Co. Ltd.
Hainan Zambon Pharmaceutical Co. Ltd
Pharmacia
Shandong Qidu Pharmaceutical Co. Ltd.
Segment by Type
For Injection
For Oral
Segment by Application
Alzheimer's Disease (AD)
Arterial Hypertension
Cerebral Thrombosis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nicergoline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nicergoline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nicergoline is an ergot derivative indicated to treat senile dementia and vascular disorders such as cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy. It is also indicated for migraines of vascular origin, coadjutant therapy in clinical situations, corio-retinal vascular disorders, oto-vestibular problems. It is sold under the brand name Sermion among others. Nicergoline is a potent vasodilator that helps improve brain blood flow by decreases vascular resistance and improving the utilization of glucose and oxygen by brain cells.
The global Nicergoline market was valued at US$ 885 million in 2023 and is anticipated to reach US$ 2354.7 million by 2030, witnessing a CAGR of 16.6% during the forecast period 2024-2030.
The global nicergoline market is projected to grow steadily. The rising burden of vascular disorders worldwide will drive the demand for Nicergoline. Rising incidences of complications due to vascular disorders are anticipated to drive the demand for Nicergoline. Increasing prevalence of cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy are projected to raise volume calls for Nicergoline. Growing FDA approval for new disease treatments is foreseen to create new growth opportunities. However, the availability of other substitutes in the market is likely to restrain the market growth. Specific challenges are roaming around the market. Adverse events have been noted associated with allergic or hypersensitivity-type reactions after the Nicergoline injection into the body. This may hinder the market growth.
This report aims to provide a comprehensive presentation of the global market for Nicergoline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicergoline.
Report Scope
The Nicergoline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicergoline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicergoline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva API
FAREVA
Olon Group
Hainan Poly Pharm Co. Ltd
DEAFARMA
Solarium Pharmaceuticals
Fengchen
LGC
Pfizer Pharmaceutical Co., Ltd.
Hebei Lingding Biotechnology Co., Ltd.
Selleck Chemicals
Tocris Bioscience
Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
Shandong Fangming Pharmaceutical Group Co. Ltd.
Hainan General Kangli Pharmaceutical Co. Ltd.
Hainan Zambon Pharmaceutical Co. Ltd
Pharmacia
Shandong Qidu Pharmaceutical Co. Ltd.
Segment by Type
For Injection
For Oral
Segment by Application
Alzheimer's Disease (AD)
Arterial Hypertension
Cerebral Thrombosis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nicergoline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nicergoline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nicergoline Market Overview
1.1 Product Overview and Scope of Nicergoline
1.2 Nicergoline Segment by Type
1.2.1 Global Nicergoline Market Value Comparison by Type (2024-2030)
1.2.2 For Injection
1.2.3 For Oral
1.3 Nicergoline Segment by Application
1.3.1 Global Nicergoline Market Value by Application: (2024-2030)
1.3.2 Alzheimer's Disease (AD)
1.3.3 Arterial Hypertension
1.3.4 Cerebral Thrombosis
1.3.5 Others
1.4 Global Nicergoline Market Size Estimates and Forecasts
1.4.1 Global Nicergoline Revenue 2019-2030
1.4.2 Global Nicergoline Sales 2019-2030
1.4.3 Global Nicergoline Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nicergoline Market Competition by Manufacturers
2.1 Global Nicergoline Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nicergoline Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nicergoline Average Price by Manufacturers (2019-2024)
2.4 Global Nicergoline Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nicergoline, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicergoline, Product Type & Application
2.7 Nicergoline Market Competitive Situation and Trends
2.7.1 Nicergoline Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nicergoline Players Market Share by Revenue
2.7.3 Global Nicergoline Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nicergoline Retrospective Market Scenario by Region
3.1 Global Nicergoline Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nicergoline Global Nicergoline Sales by Region: 2019-2030
3.2.1 Global Nicergoline Sales by Region: 2019-2024
3.2.2 Global Nicergoline Sales by Region: 2025-2030
3.3 Global Nicergoline Global Nicergoline Revenue by Region: 2019-2030
3.3.1 Global Nicergoline Revenue by Region: 2019-2024
3.3.2 Global Nicergoline Revenue by Region: 2025-2030
3.4 North America Nicergoline Market Facts & Figures by Country
3.4.1 North America Nicergoline Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nicergoline Sales by Country (2019-2030)
3.4.3 North America Nicergoline Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nicergoline Market Facts & Figures by Country
3.5.1 Europe Nicergoline Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nicergoline Sales by Country (2019-2030)
3.5.3 Europe Nicergoline Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicergoline Market Facts & Figures by Country
3.6.1 Asia Pacific Nicergoline Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nicergoline Sales by Country (2019-2030)
3.6.3 Asia Pacific Nicergoline Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nicergoline Market Facts & Figures by Country
3.7.1 Latin America Nicergoline Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nicergoline Sales by Country (2019-2030)
3.7.3 Latin America Nicergoline Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nicergoline Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicergoline Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nicergoline Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nicergoline Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicergoline Sales by Type (2019-2030)
4.1.1 Global Nicergoline Sales by Type (2019-2024)
4.1.2 Global Nicergoline Sales by Type (2025-2030)
4.1.3 Global Nicergoline Sales Market Share by Type (2019-2030)
4.2 Global Nicergoline Revenue by Type (2019-2030)
4.2.1 Global Nicergoline Revenue by Type (2019-2024)
4.2.2 Global Nicergoline Revenue by Type (2025-2030)
4.2.3 Global Nicergoline Revenue Market Share by Type (2019-2030)
4.3 Global Nicergoline Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nicergoline Sales by Application (2019-2030)
5.1.1 Global Nicergoline Sales by Application (2019-2024)
5.1.2 Global Nicergoline Sales by Application (2025-2030)
5.1.3 Global Nicergoline Sales Market Share by Application (2019-2030)
5.2 Global Nicergoline Revenue by Application (2019-2030)
5.2.1 Global Nicergoline Revenue by Application (2019-2024)
5.2.2 Global Nicergoline Revenue by Application (2025-2030)
5.2.3 Global Nicergoline Revenue Market Share by Application (2019-2030)
5.3 Global Nicergoline Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva API
6.1.1 Teva API Corporation Information
6.1.2 Teva API Description and Business Overview
6.1.3 Teva API Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva API Nicergoline Product Portfolio
6.1.5 Teva API Recent Developments/Updates
6.2 FAREVA
6.2.1 FAREVA Corporation Information
6.2.2 FAREVA Description and Business Overview
6.2.3 FAREVA Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.2.4 FAREVA Nicergoline Product Portfolio
6.2.5 FAREVA Recent Developments/Updates
6.3 Olon Group
6.3.1 Olon Group Corporation Information
6.3.2 Olon Group Description and Business Overview
6.3.3 Olon Group Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Olon Group Nicergoline Product Portfolio
6.3.5 Olon Group Recent Developments/Updates
6.4 Hainan Poly Pharm Co. Ltd
6.4.1 Hainan Poly Pharm Co. Ltd Corporation Information
6.4.2 Hainan Poly Pharm Co. Ltd Description and Business Overview
6.4.3 Hainan Poly Pharm Co. Ltd Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hainan Poly Pharm Co. Ltd Nicergoline Product Portfolio
6.4.5 Hainan Poly Pharm Co. Ltd Recent Developments/Updates
6.5 DEAFARMA
6.5.1 DEAFARMA Corporation Information
6.5.2 DEAFARMA Description and Business Overview
6.5.3 DEAFARMA Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DEAFARMA Nicergoline Product Portfolio
6.5.5 DEAFARMA Recent Developments/Updates
6.6 Solarium Pharmaceuticals
6.6.1 Solarium Pharmaceuticals Corporation Information
6.6.2 Solarium Pharmaceuticals Description and Business Overview
6.6.3 Solarium Pharmaceuticals Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Solarium Pharmaceuticals Nicergoline Product Portfolio
6.6.5 Solarium Pharmaceuticals Recent Developments/Updates
6.7 Fengchen
6.6.1 Fengchen Corporation Information
6.6.2 Fengchen Description and Business Overview
6.6.3 Fengchen Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fengchen Nicergoline Product Portfolio
6.7.5 Fengchen Recent Developments/Updates
6.8 LGC
6.8.1 LGC Corporation Information
6.8.2 LGC Description and Business Overview
6.8.3 LGC Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LGC Nicergoline Product Portfolio
6.8.5 LGC Recent Developments/Updates
6.9 Pfizer Pharmaceutical Co., Ltd.
6.9.1 Pfizer Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Pfizer Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pfizer Pharmaceutical Co., Ltd. Nicergoline Product Portfolio
6.9.5 Pfizer Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Hebei Lingding Biotechnology Co., Ltd.
6.10.1 Hebei Lingding Biotechnology Co., Ltd. Corporation Information
6.10.2 Hebei Lingding Biotechnology Co., Ltd. Description and Business Overview
6.10.3 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product Portfolio
6.10.5 Hebei Lingding Biotechnology Co., Ltd. Recent Developments/Updates
6.11 Selleck Chemicals
6.11.1 Selleck Chemicals Corporation Information
6.11.2 Selleck Chemicals Nicergoline Description and Business Overview
6.11.3 Selleck Chemicals Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Selleck Chemicals Nicergoline Product Portfolio
6.11.5 Selleck Chemicals Recent Developments/Updates
6.12 Tocris Bioscience
6.12.1 Tocris Bioscience Corporation Information
6.12.2 Tocris Bioscience Nicergoline Description and Business Overview
6.12.3 Tocris Bioscience Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Tocris Bioscience Nicergoline Product Portfolio
6.12.5 Tocris Bioscience Recent Developments/Updates
6.13 Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
6.13.1 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Corporation Information
6.13.2 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Description and Business Overview
6.13.3 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
6.13.5 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Developments/Updates
6.14 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
6.14.1 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Corporation Information
6.14.2 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Description and Business Overview
6.14.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
6.14.5 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Developments/Updates
6.15 Shandong Fangming Pharmaceutical Group Co. Ltd.
6.15.1 Shandong Fangming Pharmaceutical Group Co. Ltd. Corporation Information
6.15.2 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Description and Business Overview
6.15.3 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product Portfolio
6.15.5 Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Developments/Updates
6.16 Hainan General Kangli Pharmaceutical Co. Ltd.
6.16.1 Hainan General Kangli Pharmaceutical Co. Ltd. Corporation Information
6.16.2 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Description and Business Overview
6.16.3 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
6.16.5 Hainan General Kangli Pharmaceutical Co. Ltd. Recent Developments/Updates
6.17 Hainan Zambon Pharmaceutical Co. Ltd
6.17.1 Hainan Zambon Pharmaceutical Co. Ltd Corporation Information
6.17.2 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Description and Business Overview
6.17.3 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product Portfolio
6.17.5 Hainan Zambon Pharmaceutical Co. Ltd Recent Developments/Updates
6.18 Pharmacia
6.18.1 Pharmacia Corporation Information
6.18.2 Pharmacia Nicergoline Description and Business Overview
6.18.3 Pharmacia Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Pharmacia Nicergoline Product Portfolio
6.18.5 Pharmacia Recent Developments/Updates
6.19 Shandong Qidu Pharmaceutical Co. Ltd.
6.19.1 Shandong Qidu Pharmaceutical Co. Ltd. Corporation Information
6.19.2 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Description and Business Overview
6.19.3 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
6.19.5 Shandong Qidu Pharmaceutical Co. Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicergoline Industry Chain Analysis
7.2 Nicergoline Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicergoline Production Mode & Process
7.4 Nicergoline Sales and Marketing
7.4.1 Nicergoline Sales Channels
7.4.2 Nicergoline Distributors
7.5 Nicergoline Customers
8 Nicergoline Market Dynamics
8.1 Nicergoline Industry Trends
8.2 Nicergoline Market Drivers
8.3 Nicergoline Market Challenges
8.4 Nicergoline Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Nicergoline Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Nicergoline Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Nicergoline Market Competitive Situation by Manufacturers in 2023
Table 4. Global Nicergoline Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Nicergoline Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Nicergoline Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Nicergoline Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Nicergoline Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Nicergoline, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nicergoline, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nicergoline, Product Type & Application
Table 12. Global Key Manufacturers of Nicergoline, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nicergoline by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicergoline as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nicergoline Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Nicergoline Sales by Region (2019-2024) & (K Units)
Table 18. Global Nicergoline Sales Market Share by Region (2019-2024)
Table 19. Global Nicergoline Sales by Region (2025-2030) & (K Units)
Table 20. Global Nicergoline Sales Market Share by Region (2025-2030)
Table 21. Global Nicergoline Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Nicergoline Revenue Market Share by Region (2019-2024)
Table 23. Global Nicergoline Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Nicergoline Revenue Market Share by Region (2025-2030)
Table 25. North America Nicergoline Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Nicergoline Sales by Country (2019-2024) & (K Units)
Table 27. North America Nicergoline Sales by Country (2025-2030) & (K Units)
Table 28. North America Nicergoline Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Nicergoline Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Nicergoline Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Nicergoline Sales by Country (2019-2024) & (K Units)
Table 32. Europe Nicergoline Sales by Country (2025-2030) & (K Units)
Table 33. Europe Nicergoline Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Nicergoline Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Nicergoline Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Nicergoline Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Nicergoline Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Nicergoline Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Nicergoline Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nicergoline Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Nicergoline Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Nicergoline Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Nicergoline Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nicergoline Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nicergoline Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Nicergoline Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Nicergoline Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Nicergoline Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Nicergoline Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Nicergoline Sales (K Units) by Type (2019-2024)
Table 51. Global Nicergoline Sales (K Units) by Type (2025-2030)
Table 52. Global Nicergoline Sales Market Share by Type (2019-2024)
Table 53. Global Nicergoline Sales Market Share by Type (2025-2030)
Table 54. Global Nicergoline Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Nicergoline Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Nicergoline Revenue Market Share by Type (2019-2024)
Table 57. Global Nicergoline Revenue Market Share by Type (2025-2030)
Table 58. Global Nicergoline Price (USD/Unit) by Type (2019-2024)
Table 59. Global Nicergoline Price (USD/Unit) by Type (2025-2030)
Table 60. Global Nicergoline Sales (K Units) by Application (2019-2024)
Table 61. Global Nicergoline Sales (K Units) by Application (2025-2030)
Table 62. Global Nicergoline Sales Market Share by Application (2019-2024)
Table 63. Global Nicergoline Sales Market Share by Application (2025-2030)
Table 64. Global Nicergoline Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Nicergoline Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Nicergoline Revenue Market Share by Application (2019-2024)
Table 67. Global Nicergoline Revenue Market Share by Application (2025-2030)
Table 68. Global Nicergoline Price (USD/Unit) by Application (2019-2024)
Table 69. Global Nicergoline Price (USD/Unit) by Application (2025-2030)
Table 70. Teva API Corporation Information
Table 71. Teva API Description and Business Overview
Table 72. Teva API Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Teva API Nicergoline Product
Table 74. Teva API Recent Developments/Updates
Table 75. FAREVA Corporation Information
Table 76. FAREVA Description and Business Overview
Table 77. FAREVA Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. FAREVA Nicergoline Product
Table 79. FAREVA Recent Developments/Updates
Table 80. Olon Group Corporation Information
Table 81. Olon Group Description and Business Overview
Table 82. Olon Group Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Olon Group Nicergoline Product
Table 84. Olon Group Recent Developments/Updates
Table 85. Hainan Poly Pharm Co. Ltd Corporation Information
Table 86. Hainan Poly Pharm Co. Ltd Description and Business Overview
Table 87. Hainan Poly Pharm Co. Ltd Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Hainan Poly Pharm Co. Ltd Nicergoline Product
Table 89. Hainan Poly Pharm Co. Ltd Recent Developments/Updates
Table 90. DEAFARMA Corporation Information
Table 91. DEAFARMA Description and Business Overview
Table 92. DEAFARMA Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. DEAFARMA Nicergoline Product
Table 94. DEAFARMA Recent Developments/Updates
Table 95. Solarium Pharmaceuticals Corporation Information
Table 96. Solarium Pharmaceuticals Description and Business Overview
Table 97. Solarium Pharmaceuticals Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Solarium Pharmaceuticals Nicergoline Product
Table 99. Solarium Pharmaceuticals Recent Developments/Updates
Table 100. Fengchen Corporation Information
Table 101. Fengchen Description and Business Overview
Table 102. Fengchen Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Fengchen Nicergoline Product
Table 104. Fengchen Recent Developments/Updates
Table 105. LGC Corporation Information
Table 106. LGC Description and Business Overview
Table 107. LGC Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. LGC Nicergoline Product
Table 109. LGC Recent Developments/Updates
Table 110. Pfizer Pharmaceutical Co., Ltd. Corporation Information
Table 111. Pfizer Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Pfizer Pharmaceutical Co., Ltd. Nicergoline Product
Table 114. Pfizer Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Hebei Lingding Biotechnology Co., Ltd. Corporation Information
Table 116. Hebei Lingding Biotechnology Co., Ltd. Description and Business Overview
Table 117. Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product
Table 119. Hebei Lingding Biotechnology Co., Ltd. Recent Developments/Updates
Table 120. Selleck Chemicals Corporation Information
Table 121. Selleck Chemicals Description and Business Overview
Table 122. Selleck Chemicals Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Selleck Chemicals Nicergoline Product
Table 124. Selleck Chemicals Recent Developments/Updates
Table 125. Tocris Bioscience Corporation Information
Table 126. Tocris Bioscience Description and Business Overview
Table 127. Tocris Bioscience Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Tocris Bioscience Nicergoline Product
Table 129. Tocris Bioscience Recent Developments/Updates
Table 130. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Corporation Information
Table 131. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Description and Business Overview
Table 132. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product
Table 134. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 135. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Corporation Information
Table 136. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Description and Business Overview
Table 137. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product
Table 139. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 140. Shandong Fangming Pharmaceutical Group Co. Ltd. Corporation Information
Table 141. Shandong Fangming Pharmaceutical Group Co. Ltd. Description and Business Overview
Table 142. Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product
Table 144. Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Developments/Updates
Table 145. Hainan General Kangli Pharmaceutical Co. Ltd. Corporation Information
Table 146. Hainan General Kangli Pharmaceutical Co. Ltd. Description and Business Overview
Table 147. Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product
Table 149. Hainan General Kangli Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 150. Hainan Zambon Pharmaceutical Co. Ltd Corporation Information
Table 151. Hainan Zambon Pharmaceutical Co. Ltd Description and Business Overview
Table 152. Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product
Table 154. Hainan Zambon Pharmaceutical Co. Ltd Recent Developments/Updates
Table 155. Pharmacia Corporation Information
Table 156. Pharmacia Description and Business Overview
Table 157. Pharmacia Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Pharmacia Nicergoline Product
Table 159. Pharmacia Recent Developments/Updates
Table 160. Shandong Qidu Pharmaceutical Co. Ltd. Corporation Information
Table 161. Shandong Qidu Pharmaceutical Co. Ltd. Description and Business Overview
Table 162. Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product
Table 164. Shandong Qidu Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Nicergoline Distributors List
Table 168. Nicergoline Customers List
Table 169. Nicergoline Market Trends
Table 170. Nicergoline Market Drivers
Table 171. Nicergoline Market Challenges
Table 172. Nicergoline Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nicergoline
Figure 2. Global Nicergoline Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Nicergoline Market Share by Type in 2023 & 2030
Figure 4. For Injection Product Picture
Figure 5. For Oral Product Picture
Figure 6. Global Nicergoline Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Nicergoline Market Share by Application in 2023 & 2030
Figure 8. Alzheimer's Disease (AD)
Figure 9. Arterial Hypertension
Figure 10. Cerebral Thrombosis
Figure 11. Others
Figure 12. Global Nicergoline Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Nicergoline Market Size (2019-2030) & (US$ Million)
Figure 14. Global Nicergoline Sales (2019-2030) & (K Units)
Figure 15. Global Nicergoline Average Price (USD/Unit) & (2019-2030)
Figure 16. Nicergoline Report Years Considered
Figure 17. Nicergoline Sales Share by Manufacturers in 2023
Figure 18. Global Nicergoline Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Nicergoline Players: Market Share by Revenue in 2023
Figure 20. Nicergoline Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Nicergoline Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Nicergoline Sales Market Share by Country (2019-2030)
Figure 23. North America Nicergoline Revenue Market Share by Country (2019-2030)
Figure 24. United States Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Nicergoline Sales Market Share by Country (2019-2030)
Figure 27. Europe Nicergoline Revenue Market Share by Country (2019-2030)
Figure 28. Germany Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Nicergoline Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Nicergoline Revenue Market Share by Region (2019-2030)
Figure 35. China Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Nicergoline Sales Market Share by Country (2019-2030)
Figure 45. Latin America Nicergoline Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Nicergoline Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Nicergoline Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Nicergoline Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Nicergoline by Type (2019-2030)
Figure 56. Global Revenue Market Share of Nicergoline by Type (2019-2030)
Figure 57. Global Nicergoline Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Nicergoline by Application (2019-2030)
Figure 59. Global Revenue Market Share of Nicergoline by Application (2019-2030)
Figure 60. Global Nicergoline Price (USD/Unit) by Application (2019-2030)
Figure 61. Nicergoline Value Chain
Figure 62. Nicergoline Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
